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Background: The incidence of adverse events after carotid endarterectomy (CEA) for women compared with men is
controversial. This report compares the incidence of perioperative stroke and death in men and women by examining the
effect of comorbidities and hospital setting on CEA outcomes.
Methods:All CEAs performed in non-Federal acute-care Virginia hospitals between 1997 and 2001were reviewed. Patient
demographics, comorbidities, and hospital characteristics were compared for possible relationships to perioperative
adverse events.
Results: A total of 14,095 CEAs were performed in 34 urban and 28 rural hospitals (9 high-volume and 53 low-volume
hospitals); 42% were performed on women, and 58% were performed on men. Women experienced a significantly higher
stroke rate (1.23%) than men (0.87%; P  .04) with bivariate analysis. However, logistic regression analysis of
comorbidities and hospital settings demonstrated that sex was actually not independently related to adverse outcomes in
CEA (P  .08). Preoperative neurologic symptoms could not be evaluated as risk factors for adverse events. Acute
coronary ischemia, history of arrhythmia, end-stage renal disease, nonwhite race, advanced age, and low hospital volume
were all significantly related to mortality. History of arrhythmia was the only factor that was significantly related to the
incidence of stroke.
Conclusions: Logistic regression analysis of comorbidities and hospital setting indicated that female sex is not indepen-
dently associated with higher mortality or a higher stroke rate during CEA. These data indicate that patients with carotid
stenosis frequently have multiple medical problems that need to be carefully examined and controlled before any single
patient or hospital factor is designated as significantly related to adverse outcomes. (J Vasc Surg 2005;41:223-30.)Some manifestations of cardiovascular disease are dif-
ferent between men and women. Women who receive
coronary artery bypass grafting for coronary artery disease
more often are older1 and diabetic2 and have a hypertrophic
left ventricle3 when compared with men who receive the
same treatment. The response to surgical therapy for coro-
nary artery disease has also been shown to be significantly
different between the sexes.4-6 Women experience higher
mortality related to coronary artery bypass grafting than
men, especially when they are younger than 50 years of
age.4 These findings lead to the question of whether sex-
based differences occur in other atherosclerotic diseases.
Carotid artery stenosis and its surgical treatment have been
examined for sex-based differences by many investiga-
tors.7-15 Two types of studies have been reported: (1)
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and (2) ad hoc analyses of data gathered in prospective
randomized trials that were designed to answer questions
unrelated to sex-based differences.14,15
The conclusions of these studies are far from uniform.
Several studies demonstrated no difference in stroke rate
between men and women.7-12 Two studies showed an
increased stroke rate for women but no difference in mor-
tality.13,14 In one of these studies, the difference in stroke
rate was significant, but the authors concluded that this
difference should not change practice.13 The Asymptom-
atic Carotid Atherosclerosis Study observed subjects for
years after carotid endarterectomy (CEA) and showed that
women had more strokes during CEA and during distant
follow-up after CEA. Overall, women in the Asymptomatic
Carotid Atherosclerosis Study derived far less benefit in
stroke protection from CEA.14 However, another study
that examined these same issues in patients treated at a
single institution was not able to reproduce these find-
ings.12 Common findings in these reports included a sig-
nificantly older age for women at the time of their CEA and
no significant difference in perioperative mortality between
men and women.7-15
CEA research to date provides no definitive answer
about whether outcome differences exist between men and
women. Perhaps the most significant controversy is
whether female sex is an independent risk factor for stroke.
If a true difference exists, then efforts must focus on iden-
tifying the etiology of the difference to optimize outcomes.
There is urgency in settling these controversies. Stroke is a
leading cause of death in the United States.16 Disability
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of aging and a substantial drain on health-care resources. As
the United States population ages, it is predictable that
increasing numbers of patients will require intervention for
carotid stenosis. With careful attention to details of patient
selection and surgical approach, CEA improves stroke
risk.14,15 Patient characteristics (degree of carotid steno-
sis14,15 and neurologic symptoms7,9,12,13,15), hospitals’ ex-
pertise (volume of procedures),17,18 and technical aspects
of the procedure (use and type of patch for closure19) have
the potential to affect outcomes of CEA. Certainly it is
important to continue the commitment to understanding
the aspects of care that have the greatest effect on out-
comes. Knowledge of these variables can be used to im-
prove patient selection and operative results.
Finally, other interventions for carotid stenosis are un-
der investigation.20-22 Carotid stenting may soon rival
CEA in the treatment of carotid stenosis in many clinical
scenarios, and direct comparison with the traditional pro-
cedure is possible only when the significant variables are
clearly understood.
Examining these data is important because the data
characterize current multi-institution practice and include
variables that reflect referral patterns and other social and
economic factors not typically obtained in prospective ran-
domized controlled trials or data reported from a single
institution. Outcome analyses also allow collection and
examination of data representing large volumes of proce-
dures. The low incidence of adverse events during CEA
makes it necessary to examine large numbers of patients to
possess sufficient statistical power to support conclusive
results.23
METHODS
Data were collected by Virginia Health Information
(VHI), a nonprofit organization charged by Virginia law to
collect, analyze, and disseminate non-Federal hospital data.
The state legislature, in accordance with chapter 7.2, sec-
tion 32.1 of the Virginia code, mandates that each hospital
in the Commonwealth submit quarterly data. Hospital
discharge data are coded, collected, and entered into the
required format for each patient. VHI then receives pa-
tient-level data that are reported in a standard electronic
format directly from approximately 100 hospitals within
120 days from the end of a discharge quarter. Errors and
discrepancies are identified in a record-by-record edit pro-
cess that includes more than 100 logical edits for each
record. Aggregate reports on the validity and accuracy rate
of the total data submission and missing data and discrep-
ancies for each field are then provided to each hospital.
Corrected records are resubmitted to VHI and re-reviewed,
re-edited, and updated in the VHI master file. Statewide
accuracy rates are also provided and were 98% or higher
during the study period. A production cycle creates distri-
bution files for use in secondary analyses.
A chart audit was performed by the thoracic, cardiac,
and vascular division of the University of Virginia’s depart-
ment of surgery, reviewing all of the cardiac surgery casesperformed in 2003. A formal chart review was compared
with the VHI data. No discrepancies were identified. In
addition, annualized CEA mortality data from the Univer-
sity of Virginia’s quality assurance program were compared
with annualized data from VHI. This demonstrated com-
plete agreement for numbers of deaths and the years they
occurred.
The study protocol was approved by the Human Inves-
tigation Committee at the University of Virginia. Informed
consent was not obtained because Health Insurance Port-
ability and Accountability Act of 1996 regulations do not
apply to the information submitted to VHI. This informa-
tion is used for public health, utilization, and policy, and
this information is not reasonably expected to reveal the
identity of any patient. The information collected is based
on the All Patient Refined Diagnostic Related Group
(APRDRG®) system (3M Company). Patients receiving
International Classification of Diseases, 9th Revision, Clin-
ical Modification (ICD-9-CM) procedure code 38.12
(CEA), in the primary position, between 1997 and 2001
were selected. Information related to their care was re-
viewed. ICD-9-CM codes were checked to ascertain that
no combined CEA and open cardiac procedures were in-
cluded in this analysis (36.03, open chest coronary artery
angioplasty; 36.611-9, bypass for heart revascularization;
36.21-9, heart revascularization by arterial implant;
36.31-9, other heart revascularization; 36.9, other opera-
tion on vessels of the heart; 35.10-4, open heart valvulo-
plasty; 35.20-8, replacement of heart valve; 35.31-9, oper-
ations on structures adjacent to the heart valves). None of
these procedure codes was identified in our analysis.
Patient data analyzed included demographics (sex,
race, and age), preoperative comorbid conditions, and ad-
verse outcomes. Comorbid conditions were identified by
using ICD-9-CM codes as follows: chronic coronary artery
disease—411 (other acute and subacute forms of ischemic
heart disease), 412 (old myocardial infarction), 413 (an-
gina), and 414 (other forms of coronary atherosclerosis);
acute coronary artery disease—410 (acute myocardial in-
farction); arrhythmia—427.3 (atrial fibrillation and flut-
ter), 427.4 (ventricular fibrillation and flutter), and 427.5
(cardiac arrest); heart failure—428 (heart failure); diabetes
mellitus—250; chronic obstructive pulmonary disease—
492.8 (emphysema) and 496 (chronic airway obstruction,
not elsewhere classified); hypertension—401.1 (essential
hypertension); and end-stage renal disease—585 (chronic
renal failure). The adverse event of perioperative stroke is
coded to 997.02 (iatrogenic cerebrovascular infarction or
hemorrhage; postoperative stroke). The comorbid condi-
tions are distinct from new perioperative events, which are
coded as complications (996-999).
Hospital characteristics were also analyzed; location
was defined as urban if the hospital was in a geographic
center with a population of 100,000 or more residents and
as rural if it was located in a geographic center with a
population of less than 100,000. Hospitals were also sepa-
rated by volume of CEAs performed. High-volume institu-
tions were defined as performing an average of 100 or more
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hospitals performed fewer than 100 CEAs per year. This
designation was chosen on the basis of two publications
reporting analyses of statewide databases in New York and
California.17,24 In addition, we repeated our analyses by
using low-volume (0-62 CEAs per year), medium-volume
(63 CEAs and 100 CEAs per year), and high-volume
(100 CEAs per year) designations for hospitals. The rate
of CEAs in Virginia for the year 2000 was calculated on the
basis of data obtained from the US Census Bureau.25
Data were analyzed with SPSS version 12.01 (SPSS Inc,
Chicago, Ill) and an Internet applet (http://www.mrs-
.umn.edu/sungurea/statlets/free/hyptest5.htm) that
performs tests of two proportions. All significance tests are
two-tailed tests of proportions with  set at .05. A series of
bivariate analyses was performed to examine sex differences
in mortality and stroke rates in rural and urban hospitals
and in high- and low-volume hospitals. After this, logistic
regression analyses were conducted to evaluate the effect of
patient sex after controlling for other patient and hospital
characteristics. No model trimming or removal of nonsig-
nificant predictors was performed. The logistic regression
analysis was performed twice: the first time using 100 CEAs
per year to differentiate high- and low-volume hospitals
and the second time using 63 CEAs per year as the upper
limit for low-volume hospitals. Two additional steps were
taken to confirm the results of the logistic regression anal-
yses. First, bootstrap logistic regression was performed to
further evaluate the interactive effect of sex with all other
factors examined on stroke and mortality. This method was
used to ensure that any interaction between sex and the
other factors examined was not due to chance. Second, the
data were re-evaluated with the combination of stroke and
mortality, excluding patients who experienced both. Fif-
teen patients had stroke and eventually died. To avoid
counting one severe complication twice, the data were
analyzed tabulating only major adverse events (stroke or
death). Bothmethods reaffirmed the findings of the logistic
regression analyses, so their details are not included in this
report.
RESULTS
A total of 14,095 CEAs were performed from 1997 to
2001: 8144 (57.8%) were performed on men, and 5950
(42.2%) were performed on women (sex was not available
for one patient). During the year 2000, 951 CEAs were
performed on women (age 65 years), and 1218 CEAs
were performed on men in the same age group (rate: 2.03
women and 3.77 men per 1000 65 years of age). There
were 11,854 (84.1%) CEAs performed at 34 urban hospi-
tals and 2241 (15.9%) CEAs performed at 28 rural hospi-
tals. Women had 1007 CEAs at rural hospitals (16.9% of
female CEAs), and men had 1234 CEAs performed at rural
hospitals (15.2% of male CEAs). There were 7087 (50.3%;
mean, 157.5 per year) CEAs performed at 9 high-volume
hospitals and 7008 (49.7%; mean, 26.4 per year) CEAs
performed at 53 low-volume hospitals. Women had 3054
CEAs at low-volume hospitals (51.3% of female CEAs),andmen had 3954CEAs at low-volume hospitals (48.6% of
male CEAs). We re-stratified data into high-volume (100
CEAs per year), medium-volume (100 CEAs and 63
CEAs per year), and low-volume (63 CEAs per year)
facilities. This yielded 49 low-volume, 4 medium-volume,
and 9 high-volume hospitals. Further results reported re-
flect the initial high- and low-volume distinction (100
CEAs per year) except where noted otherwise.
Patient characteristics. Age, race, and preoperative
comorbidities were compared between men and women
(Table I). Women were more likely than men to be older,
nonwhite, and diabetic; have congestive heart failure; and
receive care in a low-volume or rural facility. Men were
more likely to have chronic coronary artery disease. Tables
II and III show the distribution of patient comorbidities in
the different hospital settings. In high-volume hospitals,
women were more likely than men to have acute coronary
artery disease. In low-volume hospitals, men were more
likely to have arrhythmia. In urban hospitals, women had a
higher rate of diabetes mellitus and congestive heart failure.
Bivariate results. Sixty-nine perioperative deaths
were reported (35 women [0.57%] and 34 men [0.43%]).
Bivariate analysis of perioperative death is contained in the
left columns of Tables IV, V, and VI. There was no signif-
icant difference in the death rate between men and women.
Overall unadjusted mortality rates were higher in rural
hospitals (P  .02) and in low-volume facilities (P  .01)
than in urban or high-volume hospital settings. A total of
144 perioperative strokes were reported. Bivariate analysis
of perioperative stroke is contained in the right columns of
Tables IV, V, and VI. Women (n  73) had a higher overall
stroke rate than men (n  71) (1.23% vs 0.87%; P  .04).
Women had a higher stroke rate than men at low-volume
(P .05) and rural (P .04) hospitals. Stroke rates did not
Table I. Comparison of age, race, hospital setting, and
comorbidities by sex
Demographic variable
Men
(n  8144)
Women
(n  5950) P value
Mean age, y (SD) 69.7 (9.1) 70.2 (9.6) .01
Nonwhite race 15.1 (1227) 17.6 (1047) .01
Hospital characteristics
Urban 84.8 (6910) 83.1 (4943) .01
Rural 15.2 (1234) 16.9 (1007) .01
High-volume 51.4 (4190) 48.7 (2896) .01
Low-volume 48.6 (3954) 51.3 (3054) .01
Comorbidities
Diabetes mellitus 5.8 (474) 7.6 (454) .01
Chronic CAD 39.7 (3232) 28.1 (1673) .01
CHF 5.4 (436) 6.2 (368) .04
COPD 15.4 (1256) 15.8 (941) .53
Hypertension 77.4 (6304) 77.3 (4600) .89
Acute CAD 0.8 (67) 0.9 (52) .52
Arrhythmia 7.1 (578) 6.4 (383) .10
ESRD 0.36 (29) 0.29 (17) .47
Data are % (n) unless otherwise noted.
CAD, Coronary artery disease; CHF, congestive heart failure; COPD,
chronic obstructive pulmonary disease; ESRD, end-stage renal disease.differ between sexes when the procedure was performed in
nic ob
nic ob
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icant difference in the overall stroke rate between high- and
low-volume facilities (P  .03), and this difference ap-
proached statistical significance for women (P  .07), but
not for men (P  .26).
We re-evaluated the data by using high-, medium-, and
low-volume hospitals as defined previously. Comparing
these institutions with one another revealed that high-
volume hospitals obtained better-than-expected results,
Table II. Patient characteristics and comorbidities by sex
Demographic variable
High-volume hospital
Men (n  4190) Women (n  2896
Mean age, y (SD) 69.3 (9.1) 69.9 (9.5)
Nonwhite race 14.8 (622) 16.5 (479)
Comorbidities
Diabetes mellitus 6.2 (258) 8.0 (233)
Chronic CAD 42.6 (1783) 29.4 (852)
CHF 5.4 (227) 6.4 (184)
COPD 14.2 (596) 14.1 (409)
Hypertension 80.0 (3351) 78.9 (2285)
Acute CAD 0.5 (21) 0.9 (25)
Arrhythmia 6.6 (277) 6.5 (187)
ESRD 0.2 (9) 0.3 (9)
Data are % (n) unless otherwise noted.
CAD, Coronary artery disease; CHF, congestive heart failure; COPD, chro
Table III. Patient characteristics and comorbidities by sex
Demographic variable
Urban hospital
Men (n  6910) Women (n  4943
Mean age, y (SD) 69.7 (9.0) 70.1 (9.6)
Nonwhite race 15.3 (1054) 17.4 (859)
Comorbidities
Diabetes mellitus 6.0 (412) 8.1 (400)
Chronic CAD 40.4 (2792) 28.4 (1406)
CHF 5.4 (375) 6.4 (317)
COPD 14.9 (1027) 15.4 (760)
Hypertension 78.0 (5390) 77.6 (3384)
Acute CAD 0.7 (51) 0.9 (44)
Arrhythmia 7.1 (494) 6.6 (324)
ESRD 0.3 (21) 0.3 (14)
Data are % (n) unless otherwise noted.
CAD, Coronary artery disease; CHF, congestive heart failure; COPD, chro
Table IV. Comparison of mortality and stroke between m
Hospital type
Mortality rate, n  69 (0.50%)
Men, n  34
(0.42%)
Women, n  35
(0.59%)
Urban 0.38% 0.51%
Rural 0.73% 0.89%
High-volume 0.26% 0.31%
Low-volume 0.61% 0.82%
Overall 0.42% 0.59%medium-volume hospitals obtained expected results, andlow-volume hospitals obtained worse-than-expected re-
sults for both death and stroke from CEA.
Multivariate results. Table VII contains the individ-
ual logistic regression results for perioperative mortality.
The factors associated with increased mortality were low-
volume hospital, age 70 years, nonwhite race, arrhyth-
mia, end-stage renal disease, and acute coronary artery
disease. Acute coronary artery disease was associated with a
nearly 25-fold increase in mortality, and arrhythmia was
ospital volume
Low-volume hospital
P value Men (n  3954) Women (n  3054) P value
.01 70.1 (9.0) 70.5 (9.7) .07
.05 15.3 (605) 18.6 (568) .01
.01 5.5 (216) 7.2 (221) .01
.01 36.6 (1449) 26.9 (821) .01
.08 5.3 (209) 6.0 (184) .21
.91 16.7 (660) 17.4 (532) .44
.26 74.7 (2953) 75.8 (2315) .29
.04 1.2 (46) 0.9 (27) .23
.87 7.6 (301) 6.4 (196) .05
.41 0.5 (20) 0.3 (8) .10
structive pulmonary disease; ESRD, end-stage renal disease.
hospital location
Rural hospital
P value Men (n  1234) Women (n  1007) P value
.01 70.0 (9.2) 70.8 (9.5) .05
.01 14.0 (173) 18.7 (188) .01
.01 5.0 (62) 5.4 (54) .67
.01 35.7 (440) 26.5 (267) .01
.02 4.9 (61) 5.1 (51) .83
.45 18.6 (229) 18.0 (181) .71
.61 74.1 (914) 76.1 (766) .28
.22 1.3 (16) 0.8 (8) .25
.29 6.8 (84) 5.9 (59) .39
.84 0.6 (8) 0.3 (3) .24
structive pulmonary disease; ESRD, end-stage renal disease.
nd women by hospital location and volume
Stroke rate, n  144 (1.02%)
lue
Men, n  71
(0.87%)
Women, n  73
(1.23%) P value
9 0.88% 1.11% .21
7 0.81% 1.79% .04
0 0.76% 0.97% .34
3 0.99% 1.50% .05
4 0.87% 1.23% .04and h
)and
)en a
P va
.2
.6
.7
.8associated with a fivefold increase in mortality. Hyperten-
.02
.01
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After controlling for these variables, patient sex did not
significantly predict perioperative mortality (P  .21).
Table VIII contains the logistic regression results for
stroke. Arrhythmia was the only factor significantly associ-
ated with occurrence of perioperative stroke, with a twofold
increase compared with patients without arrhythmia. Both
chronic coronary artery disease and hypertension were as-
sociated with a significantly decreased incidence of stroke.
Patient sex did not significantly predict perioperative stroke
(P  .08).
We performed the same multivariate analyses as de-
scribed previously with 63 CEAs per year as the minimum
number of procedures required of a high-volume hospital.
All of the characteristics that reached significance in the first
analysis remained significant in the second analysis, and no
new significant characteristics were identified, except that
low-volume hospital was an independent risk factor for
stroke, but not for death (P  .025 and P  .61, respec-
tively).
DISCUSSION
Many significant differences exist between men and
women in this CEA population. Women were nonwhite,
older, diabetic and sought care at rural and low-volume
hospitals more frequently than men. Women were also
diagnosed with chronic coronary artery disease less fre-
quently than men and diagnosed with congestive heart
failure more frequently than men. Nonwhite race, ad-
vanced age, and treatment at a low-volume hospital were all
significantly associated with higher mortality. The diagno-
sis of chronic coronary artery disease was associated with a
decreased occurrence of perioperative stroke. This demon-
strates why bivariate analyses of CEA outcomes suggest
that women have a higher incidence of perioperative ad-
verse events. Women have a different risk profile when they
Table V. Comparison of mortality and stroke in urban an
Sex
Mortality rate
Urban hospital Rural hospital P
Men 0.38% 0.73%
Women 0.51% 0.89%
Overall 0.43% 0.80%
Table VI. Comparison of mortality and stroke in high- an
Sex
Mortality rate
High-volume
hospital
Low-volume
hospital P
Men 0.26% 0.61%
Women 0.31% 0.82%
Overall 0.28% 0.70%receive surgical treatment for carotid stenosis.These findings emphasize that thorough multivariate
analyses are necessary to identify independent factors that
truly affect outcomes. Female sex is not an independent risk
factor associated with a higher incidence of death or stroke
in this population. However, the indication for surgery
could not be assessed as a risk factor for adverse outcomes
with this database based on the APRDRG® system.26
Unfortunately, the cerebral infarction, transient ischemic
attack, and amaurosis codes are nonspecific in terms of the
involved hemisphere and timing of the event. For example,
a patient may have a stroke 10 years before CEA or a stroke
on the side of the brain contralateral to the carotid stenosis
and be considered a symptomatic patient with this type of
data analysis. Several reports7,9,12,13 have demonstrated
that patients with preoperative neurologic symptoms re-
lated to the carotid stenosis being treated fared worse in
terms of perioperative stroke and death. These differences
did not always reach significance, but this finding is too
consistent to ignore. Men and women may have signifi-
cantly different indications for CEA, and this may affect the
results of this analysis. One possible solution for this prob-
lem is the use of a specific ICD-9-CM code for symptom-
atic patients requiring CEA (this would require that a new
procedure code be introduced for this entity, similar to the
ICD-9-CM code for ruptured abdominal aortic aneurysm
that is distinct from elective repair). This change would
allow use of large data repositories to better analyze these
issues.
Why do women have a risk profile that is different from
that of men? Unfortunately, data analysis of this type can-
not answer this question. It is possible that many of the
characteristics that differ significantly between men and
women can be explained by a unifying theory. Women are
probably still considered to be at lower risk than men for
cardiovascular disease by both their health-care providers
and themselves.27 This situation may delay diagnosis of
al hospitals by sex
Stroke rate
e Urban hospital Rural hospital P value
0.88% 0.81% .81
1.11% 1.79% .07
0.98% 1.25% .24
w-volume hospitals by sex
Stroke rate
e
High-volume
hospital
Low-volume
hospital P value
0.76% 0.99% .26
0.97% 1.50% .07
0.84% 1.20% .03d rur
valu
.09
.15d lo
valu
.02
.01carotid stenosis and coronary artery disease. This would
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addition, women are less frequently diagnosed with chronic
coronary artery disease. The diagnosis of chronic coronary
artery disease and hypertension was associated with im-
proved outcomes of CEA in this study. These findings seem
to be counterintuitive because more comorbid illnesses
should increase adverse perioperative events. However,
these two diagnoses may actually be markers for better
overall medical care. Hypertension was shown to be nega-
tively associated with adverse CEA outcomes in a report by
Dardik et al.28 Subjects who have been evaluated for these
conditions may receive aggressive risk-factor management
and appropriate medical therapy, including the use of
-blockers, antiplatelet therapy, and lipid-lowering medi-
cations. Chronic and perioperative use of antiplatelet med-
Table VII. Logistic regression results for perioperative mo
Variable -coefficient P
Rural hospital 0.28
Low-volume hospital 0.67
Age 70 y 0.57
Nonwhite race 0.85 
Arrhythmia 1.64 
Acute CAD 3.17 
Chronic CAD 0.17
CHF 0.47
Diabetes mellitus 0.16
COPD 0.36
Hypertension 1.06 
ESRD 1.81
Sex (female) 0.32
Constant 6.41
CI, Confidence interval; OR, odds ratio; CAD, coronary artery disease; CH
end-stage renal disease.
Table VIII. Logistic regression results for perioperative st
Variable -coefficient P
Rural hospital 0.07
Low-volume hospital 0.27
Age 70 y 0.15
Nonwhite race 0.23
Arrhythmia 0.85
Acute CAD 1.01
Chronic CAD 0.55
CHF 0.31
Diabetes mellitus 0.21
COPD 0.13
Hypertension 0.44
ESRD 0.53
Sex (female) 0.30
Constant 4.51
CI, Confidence interval; OR, odds ratio; CAD, coronary artery disease; CH
end-stage renal disease.ication29 and medical management of coronary ischemia(including the use of -blockade)30,31 have been shown to
protect patients from adverse outcomes during other sur-
gical procedures, and this principle may apply to CEA as
well.32 Failure to diagnose women with chronic coronary
artery disease may predispose them to a higher rate of
adverse perioperative events during CEA because they may
not be receiving optimal medical management. In addition,
failure to diagnose women with chronic coronary artery
disease also makes women seem to be a lower-risk group
when compared with men because most reports categorize
patients by the number of comorbidities.
The APRDRG system does allow the collection of
significant detail related to diagnoses of heart diseases.
Many investigators group all diagnoses related to the heart
into one category. We used four different categories to
ty
e OR
95.0% CI for OR
Lower Upper
1.33 0.73 2.43
1.96 1.10 3.49
1.76 1.02 3.03
2.33 1.34 4.06
5.15 2.96 8.97
23.76 11.30 49.96
1.18 0.63 2.20
1.60 0.80 3.19
1.17 0.47 2.91
1.44 0.80 2.57
0.35 0.19 0.64
6.12 1.46 25.76
1.37 0.84 2.24
0.00
gestive heart failure; COPD, chronic obstructive pulmonary disease; ESRD,
e OR
95.0% CI for OR
Lower Upper
1.07 0.68 1.69
1.31 0.90 1.89
0.86 0.61 1.20
1.26 0.83 1.92
2.34 1.42 3.84
2.73 0.94 7.95
0.58 0.37 0.90
1.37 0.73 2.54
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congestive heart failure. These results demonstrate that
separating different aspects of heart disease may allow a
further understanding of why perioperative adverse events
occur during CEA. Arrhythmia is the only comorbid dis-
ease in our analysis with a significant association to periop-
erative stroke. Hannan et al,24 examining a similar state-
wide database, described increased mortality in patients
undergoing CEA who also had atrial fibrillation or cardiac
valvular disorders. The incidence of perioperative stroke
was not reported, but the increased mortality in patients
with atrial fibrillation may be related to a perioperative
stroke. The explanation for the association between ar-
rhythmia and perioperative stroke may include a higher
incidence of thromboembolic events in these patients or
the use of different medical regimens for anticoagulation
and antiplatelet therapy in the perioperative period. For
example, patients with long-standing atrial fibrillation may
be chronically treated with warfarin. Antiplatelet medica-
tions may be withheld because of the risk of bleeding.
Warfarin administration could be discontinued for several
days before and after surgery, and the patient might be
hypercoagulable during the perioperative period. This
would predispose the patient to thrombosis of the carotid
artery or formation of an embolus that may lead to stroke.
The effect of advanced patient age on CEA outcomes is
controversial. Perler et al,33 examining this specific issue by
using a statewide database, concluded that advanced age
was not related to perioperative stroke or death in patients
treated with CEA. However, Wennberg et al,26 using a
medicare database, found a strong association between
advancing age and mortality. Hannan et al24 also reported
significantly highermortality with advanced age for patients
treated with CEA. This study also demonstrates that age
greater than 70 years is an independent risk factor for
mortality. We included age in our analysis because pub-
lished reports indicate that it affects the outcome of CEA
and because many previous evaluations of sex-based differ-
ences in CEA outcomes noted significant age differences
between men and women at the time of their CEA.7-15
Several studies17,18,24,26,33 suggest that both surgeon
and hospital volume have an effect on adverse perioperative
events during CEA. Our results indicate that facility vol-
ume behaves like a continuous variable, and results ob-
tained with bivariate analysis did not reach significance after
multivariate analysis. For example, high-volume hospitals
were not associated with a significant decrease in the stroke
or death rate after multivariate analysis, even though out-
comes in these hospitals seemed significantly better than
those in low-volume hospitals by using unadjusted data.
Multivariate analysis did indicate that low-volume hospitals
had either a significantly higher stroke or death rate, de-
pending on the upper limits of procedures per year used to
define these hospitals. Many studies found that designation
of low-, medium-, and high-volume is important in evalu-
ating this variable.18,26,33 Conversely, two publica-
tions17,24 indicate that a hospital volume of 100 CEAs per
year is an appropriate single separation between high- andlow-volume facilities. Despite this controversy, one impor-
tant consideration is that this variable be included in some
form because women received care at low-volume facilities
at a higher rate than men. Failure to include hospital
volume may result in attributing worse outcomes to female
sex.
The cohort of nonwhite subjects in this report was
larger than in many previous publications.26,28,34 In this
analysis, nonwhite race was associated with higher mortal-
ity, and this finding is consistent with previous publica-
tions.26,28 The goal of this work was to determine differ-
ences between sexes. Applying these results to examine
racial differences in outcome would be inappropriate. Fur-
ther studies need to be performed to corroborate these
findings.
The rate of CEAs was higher for men (3.77 per 1000
men65 years of age) than women (2.03 per 1000 women
in the same age group) during the year 2000 for patients
treated in non-Federal hospitals in Virginia. The overall
rate for this age group in Virginia in 2000 was 3.1, which
compares to a national rate of 3.3 during the same year for
the same age group.35 This information does not convey
the prevalence of carotid stenosis that should be treated for
either sex. This information is not known,36 so it is difficult
to interpret whether the sex prevalence in this study ade-
quately reflects all patients who should be treated.
In conclusion, sex was not an independent risk factor
for stroke or death in this population, although limita-
tions in the data analyzed preclude examination of the
indication for operation as a risk factor for adverse out-
comes. Positive associations were identified between ad-
verse events and arrhythmias, advanced age, nonwhite
race, end-stage renal disease, and low-volume facilities.
The diagnosis of hypertension or chronic coronary artery
disease had a negative association with perioperative
stroke and death. Women had a worse risk profile for the
prevalence of these important factors when compared
with men in this study. Further investigation should be
performed to evaluate differences in the prevalence of
carotid stenosis and differences in optimal perioperative
medical management between men and women.
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